AstraZeneca

Products

Category

Product

Brand

Description

Global Insulin Pen Market (MDS102A)

Dapagliflozin	Forxiga or Farxiga	Forxiga and Farxiga are trade names for dapagliflozin, a medication classified as an SGLT2 inhibitor, indicated for managing type 2 diabetes through blood sugar level reduction.
Dapagliflozin/metformin	Ebymect	It is classified as SGLT2 inhibitors. Ebymect is a medication for managing type 2 diabetes in adults. It can be administered alongside dietary adjustments and physical activity.
Dapagliflozin	Edistride	Edistride is a medication employed in the management of type 2 diabetes, chronic (long-term) heart failure, and chronic kidney disease.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.